Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
182,917,028
-
Total 13F shares
-
14,000,592
-
Share change
-
+211,755
-
Total reported value
-
$192,282,000
-
Price per share
-
$13.88
-
Number of holders
-
22
-
Value change
-
+$2,926,211
-
Number of buys
-
11
-
Number of sells
-
6
Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q1 2016
As of 31 Mar 2016,
Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,000,592 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, FMR LLC, Foresite Capital Management III, LLC, Redmile Group, LLC, New Leaf Venture Partners, L.L.C., Cormorant Asset Management, LLC, CLOUGH CAPITAL PARTNERS L P, JENNISON ASSOCIATES LLC, PERCEPTIVE ADVISORS LLC, and VANGUARD GROUP INC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.